Albert Schilling
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
- Oncology top 10%
- Cancer Treatment and Pharmacology
- CAR-T cell therapy research
- Cutaneous Melanoma Detection and Management
- Bone health and treatments
- Peptidase Inhibition and Analysis
Papers in
- Oncology 9
- Cancer Treatment and Pharmacology 6
-
- Multiple Myeloma Research and Treatments 7
- Co-authors
- Larry Nathanson (3 shared papers)Oliver Glidewell (2 shared papers)A. C. Ritchie (1 shared paper)H. Robert Dudley (1 shared paper)William H. Baker (1 shared paper)Jacob Colsky (2 shared papers)Janet Wolter (2 shared papers)Ralph L. Nachman (1 shared paper)
- Journals
- Cancer (4 papers)New England Journal of Medicine (3 papers)Clinical Pharmacology & Therapeutics (1 paper)Medical Clinics of North America (1 paper)Journal of Clinical Oncology (1 paper)
- Partner nations
- United StatesGermanyBrazil
In The Last Decade
Albert Schilling
26 papers receiving 547 citations
Peers
Comparison fields: 5 of 99
- Hematology 206
- Oncology 276
- Genetics 53
- Nephrology 28
- Pathology and Forensic Medicine 54
Countries citing papers authored by Albert Schilling
This map shows the geographic impact of Albert Schilling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Albert Schilling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Albert Schilling more than expected).
Fields of papers citing papers by Albert Schilling
This network shows the impact of papers produced by Albert Schilling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Albert Schilling. The network helps show where Albert Schilling may publish in the future.
Co-authors
The 25 scholars most cited alongside Albert Schilling, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1973 | 114 | |
| 2 | 1955 | 101 | |
| 3 | 1971 | 79 | |
| 4 | 1967 | 53 | |
| 5 | 1972 | 52 | |
| 6 | Intermittent high-dose prednisone (NSC-10023) therapy for multiple myeloma. | 1967 | 40 |
| 7 | 1972 | 39 | |
| 8 | 2002 | 37 | |
| 9 | Concurrent combination chemotherapy of human solid tumors: experience with a three-drug regimen and review of the literature. | 1969 | 36 |
| 10 | 1987 | 28 | |
| 11 | 1997 | 27 | |
| 12 | Phase III study of intermittent carmustine (BCNU), cyclophosphamide, and prednisone versus intermittent melphalan and prednisone in myeloma. | 1982 | 20 |
| 13 | [Choroid metastasis in a patient with adenocarcinoma of the cervix. A case report]. | 1995 | 13 |
| 14 | 1963 | 9 | |
| 15 | Resection of multiple lung metastases--where are the limits? | 2005 | 7 |
| 16 | 1977 | 5 | |
| 17 | 1995 | 5 | |
| 18 | 2007 | 4 | |
| 19 | 1953 | 4 | |
| 20 | 1966 | 4 |
About Albert Schilling
Albert Schilling is a scholar working on Oncology, Hematology, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Physiology, having authored 28 papers that have together received 685 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (7 papers), Cancer Treatment and Pharmacology (6 papers), Drug-Induced Hepatotoxicity and Protection (2 papers), Smoking Behavior and Cessation (2 papers), Bone and Joint Diseases (2 papers), Melanoma and MAPK Pathways (2 papers), Cancer therapeutics and mechanisms (2 papers) and Medical Imaging and Pathology Studies (2 papers). The work is most often cited by research in Hematology (206 citations), Oncology (276 citations), Genetics (53 citations), Nephrology (28 citations) and Pathology and Forensic Medicine (54 citations). Albert Schilling has collaborated with scholars based in United States, Germany and Brazil. Frequent co-authors include Larry Nathanson, Oliver Glidewell, A. C. Ritchie, H. Robert Dudley, William H. Baker, Jacob Colsky, Janet Wolter, Ralph L. Nachman, Ralph L. Engle and Paul P. Carbone. Their work appears in journals such as Cancer, New England Journal of Medicine, Clinical Pharmacology & Therapeutics, Medical Clinics of North America and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.